ReP USP - Resultado da busca

Artigo de periodico
Long-Term Evolocumab in Patients With Familial Hypercholesterolemia (2020)
Santos Filho, Raul Dias dos ; Stein, Evan A.; Hovingh, G. Kees; Blom, Dirk J; Soran, Handrean; Watts, Gerald F; Lopez, J. Antonio G; Bray, Sarah; Kurtz, Christopher E; Hamer, Andrew W
Fonte: Journal of the american college of cardiology. Unidade: FM
Assuntos: HIPERCOLESTEROLEMIA, ANTICORPOS MONOCLONAIS, ENZIMAS PROTEOLÍTICAS, ANTIMETABÓLITOS, RESULTADO DE TRATAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS FILHO, Raul Dias dos et al. Long-Term Evolocumab in Patients With Familial Hypercholesterolemia. Journal of the american college of cardiology, v. 75, n. 6, p. 565-574, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2019.12.020. Acesso em: 15 nov. 2024.
APA
Santos Filho, R. D. dos, Stein, E. A., Hovingh, G. K., Blom, D. J., Soran, H., Watts, G. F., et al. (2020). Long-Term Evolocumab in Patients With Familial Hypercholesterolemia. Journal of the american college of cardiology, 75( 6), 565-574. doi:10.1016/j.jacc.2019.12.020
NLM
Santos Filho RD dos, Stein EA, Hovingh GK, Blom DJ, Soran H, Watts GF, Lopez JAG, Bray S, Kurtz CE, Hamer AW. Long-Term Evolocumab in Patients With Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2020 ; 75( 6): 565-574.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jacc.2019.12.020
Vancouver
Santos Filho RD dos, Stein EA, Hovingh GK, Blom DJ, Soran H, Watts GF, Lopez JAG, Bray S, Kurtz CE, Hamer AW. Long-Term Evolocumab in Patients With Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2020 ; 75( 6): 565-574.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jacc.2019.12.020
Artigo de periodico
Impact of age on the efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia (2019)
Ginsberg, Henry N; Tuomilehto, Jaakko; Hovingh, G. Kees; Cariou, Bertrand; Santos Filho, Raul Dias dos; Brown, Alan S; Sanganalmath, Santosh K; Koren, Andrew; Thompson, Desmond; Raal, Frederick J
Fonte: Cardiovascular drugs and therapy. Unidade: FM
Assuntos: HIPERCOLESTEROLEMIA, ERROS INATOS DO METABOLISMO, ENZIMAS PROTEOLÍTICAS, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GINSBERG, Henry N et al. Impact of age on the efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia. Cardiovascular drugs and therapy, v. 33, n. 1, p. 69-76, 2019Tradução . . Disponível em: https://doi.org/10.1007/s10557-019-06852-6. Acesso em: 15 nov. 2024.
APA
Ginsberg, H. N., Tuomilehto, J., Hovingh, G. K., Cariou, B., Santos Filho, R. D. dos, Brown, A. S., et al. (2019). Impact of age on the efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia. Cardiovascular drugs and therapy, 33( 1), 69-76. doi:10.1007/s10557-019-06852-6
NLM
Ginsberg HN, Tuomilehto J, Hovingh GK, Cariou B, Santos Filho RD dos, Brown AS, Sanganalmath SK, Koren A, Thompson D, Raal FJ. Impact of age on the efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia [Internet]. Cardiovascular drugs and therapy. 2019 ; 33( 1): 69-76.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s10557-019-06852-6
Vancouver
Ginsberg HN, Tuomilehto J, Hovingh GK, Cariou B, Santos Filho RD dos, Brown AS, Sanganalmath SK, Koren A, Thompson D, Raal FJ. Impact of age on the efficacy and safety of alirocumab in patients with heterozygous familial hypercholesterolemia [Internet]. Cardiovascular drugs and therapy. 2019 ; 33( 1): 69-76.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1007/s10557-019-06852-6
Artigo de periodico
Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system (2018)
Bahia, Luciana R.; Santos, Raul D.; Araujo, Denizar V.; Rosa, Roger S.; Bahia, Luciana R.
Fonte: Archives of endocrinology metabolism. Unidade: FM
Assuntos: PACIENTES INTERNADOS, CUSTOS DOS CUIDADOS DE SAÚDE, DOENÇAS CARDIOVASCULARES, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BAHIA, Luciana R. et al. Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system. Archives of endocrinology metabolism, v. 62, n. 3, p. 303-308, 2018Tradução . . Disponível em: https://doi.org/10.20945/2359-3997000000030. Acesso em: 15 nov. 2024.
APA
Bahia, L. R., Santos, R. D., Araujo, D. V., Rosa, R. S., & Bahia, L. R. (2018). Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system. Archives of endocrinology metabolism, 62( 3), 303-308. doi:10.20945/2359-3997000000030
NLM
Bahia LR, Santos RD, Araujo DV, Rosa RS, Bahia LR. Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system [Internet]. Archives of endocrinology metabolism. 2018 ; 62( 3): 303-308.[citado 2024 nov. 15 ] Available from: https://doi.org/10.20945/2359-3997000000030
Vancouver
Bahia LR, Santos RD, Araujo DV, Rosa RS, Bahia LR. Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system [Internet]. Archives of endocrinology metabolism. 2018 ; 62( 3): 303-308.[citado 2024 nov. 15 ] Available from: https://doi.org/10.20945/2359-3997000000030
Artigo de periodico
Clinical Genetic Testing for Familial Hypercholesterolemia (2018)
Sturm, Amy C.; Santos, Raul D.
Fonte: Journal of the american college of cardiology. Unidade: FM
Assuntos: HIPERCOLESTEROLEMIA, DOENÇAS CARDIOVASCULARES, COLESTEROL, CUSTOS DOS CUIDADOS DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
STURM, Amy C. e SANTOS, Raul D. Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, v. 72, n. 6, p. 662-680, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.05.044. Acesso em: 15 nov. 2024.
APA
Sturm, A. C., & Santos, R. D. (2018). Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, 72( 6), 662-680. doi:10.1016/j.jacc.2018.05.044
NLM
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jacc.2018.05.044
Vancouver
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jacc.2018.05.044
Artigo de periodico
Familial hypercholesterolaemia (2017)
Defesche, Joep C.; Gidding, Samuel S.; Harada-Shiba, Mariko; Santos Filho, Raul Dias dos; Wierzbicki, Anthony S.
Fonte: Nature reviews disease primers. Unidade: FM
Assuntos: HIPERCOLESTEROLEMIA, COLESTEROL, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DEFESCHE, Joep C. et al. Familial hypercholesterolaemia. Nature reviews disease primers, v. 3, 2017Tradução . . Disponível em: https://doi.org/10.1038/nrdp.2017.93. Acesso em: 15 nov. 2024.
APA
Defesche, J. C., Gidding, S. S., Harada-Shiba, M., Santos Filho, R. D. dos, & Wierzbicki, A. S. (2017). Familial hypercholesterolaemia. Nature reviews disease primers, 3. doi:10.1038/nrdp.2017.93
NLM
Defesche JC, Gidding SS, Harada-Shiba M, Santos Filho RD dos, Wierzbicki AS. Familial hypercholesterolaemia [Internet]. Nature reviews disease primers. 2017 ; 3[citado 2024 nov. 15 ] Available from: https://doi.org/10.1038/nrdp.2017.93
Vancouver
Defesche JC, Gidding SS, Harada-Shiba M, Santos Filho RD dos, Wierzbicki AS. Familial hypercholesterolaemia [Internet]. Nature reviews disease primers. 2017 ; 3[citado 2024 nov. 15 ] Available from: https://doi.org/10.1038/nrdp.2017.93

Unidades USP

ReP

Filtros

Autores

Assuntos

Agência de fomento